ADC Therapeutics SA (ADCT) Operating margin 2022–2025
ADC Therapeutics SA (ADCT) operating margin by fiscal year — reported operating income divided by reported revenue.
-149.3%FY2025 · since FY2022: -164.7% → -149.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -149.3% | +35.1 pp |
| FY2024 | -184.4% | +55.9 pp |
| FY2023 | -240.4% | -75.7 pp |
| FY2022 | -164.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →